Identification of specific sites in the TNF-α molecule promoting insulin resistance in H-411E cells

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 2, 1997, Pages 139-146

  Solomon, Solomon S ^a,b   Mishra, Sanjay K ^a   Palazzolo, Marjorie R ^a   Postlethwaite, Arnold E ^a   Sever, Jerome M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031214603     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90090-1     Document Type: Article

References (30)

1. Old LJ. Tumor necrosis factor (TNF). Science 1985;230: 630-3.
2. Pekala PH, Kawakami M, Angus CW, Lane MD, Cerami A. Selective inhibition of synthesis of enzymes for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells. Proc Natl Acad Sci 1983;80:2743-7.
3. Pekala PH, Price SR, Horn CA, Horn BE, Moss J, Cerami A. Model for cachexia in chronic disease: secretory products of endotoxin-stimulated macrophages induce a catabolic state in 3T3-L1 adipocytes. Trans Assoc Am Physicians 1984;97:251-9.
4. Haranaka K, Satomi N, Sakurai A, Nariuchi H. Purification and partial amino acid sequence of rabbit tumor necrosis factor. Int J Cancer 1985;36:395.
5. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984;312:724-8.
6. Grunfeld C, Feingold KR. The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 1991;3:143-58.
7. Vilcek J, Lee TH. Tumor necrosis factor: new insights into the molecular mechanisms of its multiple actions. J Biol Chem 1991;266:7313-6.
8. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesitylinked insulin resistance. Science 1993;289:87-91.
9. Hotamisligil GS, Budavari A, Murray DL, Speigelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-α. J Clin Invest 1994;94:1543-9.
10. Stephens JM, Pekala PH. Transcriptional repression of the GLUT4 and CEBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem 1991;266:21839-45.
11. Solomon SS, Palazzolo MR, Elam MB, Green SA, Raghow RS. Regulation of calmodulin gene expression by insulin is both transcriptional and post-transcriptional. J Lab Clin Med 1994;124:348-58.
12. Solomon SS, Kitabchi AE. Studies of adenosine and dibutyryl adenosine 3′,5′-monophosphoric acid on the isolated fat cell. Diabetes 1972;21:1027-34.
13. Solomon SS, Palazzolo MR, Smoake JA, Raghow RS. Insulin-stimulated calmodulin gene expression in rat H-411E cells can be selectively blocked by antisense oligonucleotides. Biochem Biophys Res Commun 1995;210:921-30.
14. Postlethwaite AE, Seyer JM. Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor-α (TNF-α) and a synthetic TNF-α 31-68 peptide. J Exp Med 1990;172:1749-56.
15. Kapas L, Hong L, Cady AB, Opp MR, Postlethwaite AE, Seyer JM, et al. Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-α and TNF-α fragments. Am J Physiol 1992;R708-15.
16. Beutler B. Tumor necrosis factors: the molecules and their emerging role in medicine. New York: Raven Press, 1992:1-590.
17. Merrifield RB. Solid phase peptide synthesis I. The synthesis of a tetrapeptide. J Am Chem Soc 1963;85:2149-54.
18. Aycock RS, Raghow R, Stricklin GP, Seyer JM, Kang AH. Post-transcriptional inhibition of collagen and fibronectin synthesis by a homolog of a portion of the carboxyl-terminal propeptide of human type I collagen. J Biol Chem 1986;261: 14355-60.
19. Kronke M, Schutze S, Scheurivh P, Pfizenmaier K. TNF signal transduction and TNF-response genes. Immunol Ser 1992;56:189-216.
20. Solomon SS, Steiner MS, Little RH, Rao H, Sanders LL, Palazzolo MR. Inhibitor of calmodulin and cAMP phosphodiesterase activity in BB rats. Diabetes 1987;36:210-5.
21. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler F, Cerami A, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986;163:1433-50.
22. Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 1992;130:43-52.
23. Eck MJ, Sprang SR. The structure of tumor necrosis factor-α at 2.6 A resolution. J Biol Chem 1989;264:17595-605.
24. Goodwin RG, Anderson D, Jerzy R, Davis T, Brannan CI, Copeland NG, et al. Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor. Mol Cell Biol 1991;11:3020-6.
25. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 1994;76:959-62.
26. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA Jr, Goeddel DV. The two different receptors for tumor necrosis factor mediate distrinct cellular responses. Proc Natl Acad Sci USA 1991;88:9292-6.
27. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992;13:151-3.
28. Kolesnick R, Golde DW. The sphingomyelin pathway in tumor necrosis factor and interleukin-I signaling. Cell 1994;77:325-8.
29. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 1993;268:26055-8.
30. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor-α inhibits signaling from the insulin receptor. Proc. Natl Acad Sci USA 1994;91:4854-8.